Patent · US Active

Cannabinoid receptor modulators

US7897601B2 · kind B2 · utility

0Cited by

48References

67Claims

0Family size

Assignees

Intervet Inc. · US
INTERVET INTERNATIONAL B.V · NL

Inventors

Samuel Chackalamannil · Califon, US
Mariappan V. Chelliah · Edison, US
Martin C. Clasby · Plainsboro, US
Keith Eagen · Long Valley, US
Jack D. Scott · Scotch Plains, US
Yuguang Wang · Shanghai, CN
Yan Xia · Edison, US
William J. Greenlee · Teaneck, US

Key dates

Filing date	Jan 16, 2007
Grant date	Mar 1, 2011
Priority date	—
Expiry date	Dec 6, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound having the general structure of Formula (I):or a pharmaceutically acceptable salt, solvate, or ester thereof, is useful in treating diseases, disorders, or conditions such as obesity, metabolic disorders, addiction, diseases of the central nervous system, cardiovascular disorders, respiratory disorders, and gastrointestinal disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.